When.com Web Search

  1. Ads

    related to: moderate persistent asthma treatment guidelines table
    • Home

      Official Patient Website—

      Get Treatment Info Today.

    • Sign Up

      Register Or Activate Your Card—

      Find Out If You're Eligible Today.

Search results

  1. Results From The WOW.Com Content Network
  2. If You're Living With Asthma, Here's Every Single Treatment ...

    www.aol.com/youre-living-asthma-heres-every...

    Treat an asthma attack by visiting the hospital. Every year, more than 1.6 million Americans wind up in the emergency room because of an asthma attack, according to the CDC.If your attack is so ...

  3. Anti-asthmatic agent - Wikipedia

    en.wikipedia.org/wiki/Anti-asthmatic_agent

    According to the Global Initiative of Asthma (GINA), the guideline for anti-asthmatic treatment is divided into 5 levels according to asthma severity. [ 31 ] For newly diagnosed asthma patients, the 5 levels derived from the severity of asthma depend on the occurrence of symptoms and their frequencies.

  4. Long-acting beta-adrenoceptor agonist - Wikipedia

    en.wikipedia.org/wiki/Long-acting_beta...

    This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta. Umeclidinium bromide is a long-acting muscarinic antagonist. [14]

  5. Asthma - Wikipedia

    en.wikipedia.org/wiki/Asthma

    Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.

  6. Asthma-COPD overlap - Wikipedia

    en.wikipedia.org/wiki/Asthma-COPD_overlap

    However, in asthma, the airflow limitation usually completely resolves after exacerbations, whereas in COPD it may not. [1] ACO presents with a chronic airflow limitation or obstruction (due to inflammation), with characteristics of both asthma and COPD. Inflammation of the large and medium airways (classically seen with asthma) is seen in ACO. [1]

  7. Omalizumab - Wikipedia

    en.wikipedia.org/wiki/Omalizumab

    Such a treatment scheme is consistent with the widely adopted guidelines for the management and prevention of asthma, issued by Global Initiative of Asthma (GINA), which was a medical guidelines organization launched in 1993 in collaboration with the National Heart, Lung, and Blood Institute, National Institutes of Health, US, and the World ...

  1. Ads

    related to: moderate persistent asthma treatment guidelines table